JAIRE Trademark

Trademark Overview

On Wednesday, July 25, 2012, a trademark application was filed for JAIRE with the United States Patent and Trademark Office. The USPTO has given the JAIRE trademark a serial number of 85686115. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 25, 2016. This trademark is owned by Glaxo Group Limited. The JAIRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
jaire

General Information

Serial Number85686115
Word MarkJAIRE
Filing DateWednesday, July 25, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 25, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 22, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "JAIRE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 31, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, April 25, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 25, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 1, 2015EXTENSION 5 GRANTED
Wednesday, July 29, 2015EXTENSION 5 FILED
Wednesday, July 29, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2015EXTENSION 4 GRANTED
Monday, March 2, 2015EXTENSION 4 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Thursday, September 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 3, 2014EXTENSION 3 GRANTED
Thursday, August 28, 2014EXTENSION 3 FILED
Thursday, August 28, 2014TEAS EXTENSION RECEIVED
Thursday, April 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 9, 2014EXTENSION 2 GRANTED
Wednesday, March 12, 2014EXTENSION 2 FILED
Monday, April 7, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 12, 2014TEAS EXTENSION RECEIVED
Thursday, September 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2013EXTENSION 1 GRANTED
Tuesday, September 10, 2013EXTENSION 1 FILED
Tuesday, September 10, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 19, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 22, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 22, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 2, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, December 16, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 4, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 27, 2012EXAMINER'S AMENDMENT ENTERED
Monday, November 26, 2012ASSIGNED TO LIE
Monday, November 26, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 26, 2012EXAMINERS AMENDMENT E-MAILED
Monday, November 26, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 21, 2012ASSIGNED TO EXAMINER
Tuesday, July 31, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 28, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

jaire pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological